Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine for Reducing Abusive Drinking in Alcoholism
NCT00680121Phase 4Completed
- Sponsor
- University of Kansas
- Start
- Jul 2008
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of benfotiamine in alcohol use disorder (AUD) (2 arms), sponsored by University of Kansas. Primary endpoint: Change in Average Daily Alcohol Consumption at 6 months. Started Jul 2008; status: completed.
02
Drugs
benfotiamine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00680121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680121.